CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473,236 | +20.5% | 10,426 | +49.0% | 0.02% | +22.2% |
Q2 2023 | $392,755 | -7.2% | 6,996 | -25.2% | 0.02% | -10.0% |
Q1 2023 | $423,262 | +47.8% | 9,358 | +32.8% | 0.02% | +25.0% |
Q4 2022 | $286,379 | -35.1% | 7,045 | +4.4% | 0.02% | -42.9% |
Q3 2022 | $441,000 | -24.0% | 6,747 | -29.3% | 0.03% | -22.2% |
Q2 2022 | $580,000 | +3.8% | 9,547 | +7.2% | 0.04% | +28.6% |
Q1 2022 | $559,000 | -1.1% | 8,909 | +19.5% | 0.03% | -9.7% |
Q4 2021 | $565,000 | -16.4% | 7,458 | +23.5% | 0.03% | -20.5% |
Q3 2021 | $676,000 | -26.2% | 6,038 | +6.8% | 0.04% | -30.4% |
Q2 2021 | $916,000 | +32.8% | 5,656 | -0.1% | 0.06% | +75.0% |
Q1 2021 | $690,000 | +20.6% | 5,661 | +51.5% | 0.03% | +10.3% |
Q4 2020 | $572,000 | +75.5% | 3,737 | -4.2% | 0.03% | 0.0% |
Q3 2020 | $326,000 | +14.8% | 3,902 | +0.9% | 0.03% | +11.5% |
Q2 2020 | $284,000 | +667.6% | 3,869 | +381.8% | 0.03% | +550.0% |
Q1 2020 | $37,000 | -19.6% | 803 | +7.1% | 0.00% | 0.0% |
Q4 2019 | $46,000 | +76.9% | 750 | +17.2% | 0.00% | +33.3% |
Q3 2019 | $26,000 | -23.5% | 640 | -11.7% | 0.00% | -25.0% |
Q2 2019 | $34,000 | +30.8% | 725 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $26,000 | +116.7% | 725 | +71.4% | 0.00% | +50.0% |
Q4 2018 | $12,000 | 0.0% | 423 | +11.6% | 0.00% | 0.0% |
Q3 2018 | $12,000 | +200.0% | 379 | +345.9% | 0.00% | +100.0% |
Q2 2018 | $4,000 | -20.0% | 85 | -19.0% | 0.00% | 0.0% |
Q1 2018 | $5,000 | +66.7% | 105 | -19.2% | 0.00% | – |
Q4 2017 | $3,000 | +200.0% | 130 | +85.7% | 0.00% | – |
Q3 2017 | $1,000 | – | 70 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |